Bradley Merrill Thompson Quoted in Article, “Tweaked FDA Bill Removes Hurdle to Medical App Guidance”


Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in an article titled "Tweaked FDA Bill Removes Hurdle to Medical App Guidance."

Following is an excerpt:

"Last night, the mobile health industry avoided a big stumbling block with the help of Congress," Brad Thompson, an FDA expert with Washington, D.C.-based law firm Epstein Becker Green who serves as general counsel for the mHealth Regulatory Coalition, said in an email to MRC members obtained by FierceMobileHealthcare.

"[T]hose who acknowledge that FDA has a legitimate role to play wanted to avoid any delay in the desire to get needed clarity around the scope of FDA regulation so that [the] industry and investors could move forward."

Thompson's letter added that with the decision "many in [the] industry breathed a sigh of relief."